Friday, March 29, 2024 12:30:42 PM
Recent AKBA News
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 12/03/2024 09:05:00 PM
- U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis • PR Newswire (US) • 12/03/2024 12:00:00 PM
- Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference • PR Newswire (US) • 11/25/2024 01:00:00 PM
- Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease • PR Newswire (US) • 11/14/2024 01:00:00 PM
- Akebia Therapeutics to Present at the Jefferies London Healthcare Conference • PR Newswire (US) • 11/12/2024 01:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/08/2024 07:17:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 12:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 12:05:26 PM
- Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights • PR Newswire (US) • 11/07/2024 12:00:00 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 11/01/2024 08:05:00 PM
- Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights • PR Newswire (US) • 11/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2024 12:05:56 PM
- Akebia Therapeutics Signs Commercial Supply Contract with Leading Dialysis Organization to Enable Access to Vafseo® (vadadustat) for Patients on Dialysis • PR Newswire (US) • 10/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 11:36:10 AM
- Akebia Therapeutics Announces Seven Poster Presentations at ASN Kidney Week 2024 • PR Newswire (US) • 10/15/2024 12:00:00 PM
- CMS Grants TDAPA Reimbursement for Vafseo® (vadadustat) beginning January 1, 2025 • PR Newswire (US) • 10/10/2024 12:00:00 PM
- Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply Contract to Enable Access to Vafseo® (vadadustat) for Patients on Dialysis • PR Newswire (US) • 10/07/2024 12:00:00 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 10/01/2024 08:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2024 04:15:10 AM
- Akebia Therapeutics and U.S. Renal Care Initiate the VOICE Trial of Vafseo® (vadadustat) for Patients on Dialysis • PR Newswire (US) • 09/05/2024 12:00:00 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 09/03/2024 08:16:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/03/2024 08:07:59 PM
- Akebia Therapeutics to Present at Upcoming Investor Conferences • PR Newswire (US) • 08/26/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:52:02 AM
Avant Technologies' Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy • AVAI • Dec 4, 2024 8:00 AM
North Bay Resources Commences Fran Gold Winter Ore Shipment to Bishop Gold Mill, California • NBRI • Dec 2, 2024 9:07 AM
VAYK Reached Agreement on Terms to Acquire $1 Million Company for Disruptive Airbnb Strategy • VAYK • Dec 2, 2024 9:00 AM
ILUS Announces Completion of QIND Acquisition by Fusion Fuel (NASDAQ: HTOO) • ILUS • Nov 27, 2024 12:35 PM
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer • BLO • Nov 26, 2024 8:48 AM
BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL • BQST • Nov 26, 2024 8:00 AM